Non-Hodgkin Lymphoma in Adults

We use molecular and genetic tests to diagnose non-Hodgkin lymphoma. This form of cancer arises in the body’s lymphatic system—the network of vessels, nodes, and other organs that drain excess fluid from tissues and help the body fight infections. These tests enable our hematologists, or blood cancer specialists, to create a personalized treatment plan for you. Approaches may include chemotherapy, targeted medications, stem cell transplantation, and radiation therapy. We can also determine whether you may benefit from new therapies being studied in clinical trials.

Clinical Trials and Research Studies

Phase 3

A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Enzastaurin Plus R-CHOP Versus R-CHOP in Treatment-Na ve Subjects with High-Risk Diffuse Large B-Cell Lymphoma Who Possess the Novel Genomic Biomarker DGM1

Phase 1/2

A Phase I/II Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma

Phase 3

PHASE III MULTICENTER RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL COMPARING EFFICACY+SAFETY OF POLATUZUMAB VEDOTIN IN COMBO WITH R-CHP VS R-CHOP IN PREVIOUSLY UNTREATED PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

Phase 1

A Phase 1a/1b Dose Escalation and Expansion Trial of TTI-621 a Novel Biologic Targeting CD47 in Subjects with Relapsed or Refractory Hematologic Malignancies and Selected Solid Tumors